FY2025 Earnings Estimate for Cytokinetics Issued By B. Riley
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Analysts at B. Riley cut their FY2025 earnings per share estimates for Cytokinetics in a note issued to investors on Wednesday, March 5th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will post earnings of ($5.65) per share for the year, down from their previous […]
Cytokinetics, Incorporated (NASDAQ:CYTK – Free Report) – Analysts at B. Riley cut their FY2025 earnings per share estimates for Cytokinetics in a note issued to investors on Wednesday, March 5th. B. Riley analyst M. Mamtani now anticipates that the biopharmaceutical company will post earnings of ($5.65) per share for the year, down from their previous […]
